Fortrea Holdings Inc.
FTRE
Fortrea Holdings Inc. is a leading global contract research organization ( CRO ), providing biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology and medical device customers. We provide phase I through IV clinical trial management, clinical pharmacology, and consulting services for our customers.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.67B
▲ +1.0% YoY
Net Income (TTM)
-$69M
▼ -200.2% YoY
Op. Margin
0.48%
▼ -26.0pp YoY
ROIC
0.61%
▼ -28.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$169M
▼ -62.8% YoY
Op. Cash Flow (TTM)
$202M
▼ -56.8% YoY
Net Debt
$898M
Cash & Equiv.
$221M
3Y CAGR: -1.4%
3Y CAGR: +46.1%
Continue Research
Peers
Services-Medical Laboratories · Pick stocks to compare with FTRE
Held by ETFs
FTRE is in 61 US ETFs. The largest of them, with FTRE's weight in each:
Fortrea Holdings (FTRE) in four numbers
Questions about Fortrea Holdings
Is Fortrea Holdings (FTRE) overvalued?
At $20.46, Fortrea Holdings' price is 88% above the $10.87 a share fair value that Intrinsiqq's calculator gets from its free cash flow. It trades at 11.68 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Fortrea Holdings' fair value?
Intrinsiqq's calculator puts Fortrea Holdings' fair value at $10.87 a share. It grows free cash flow per share 0% a year for 5 years, applies an exit P/FCF of 10, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $8.16. Every input can be changed on the Intrinsic Value tab.
Is Fortrea Holdings a high-quality business?
Fortrea Holdings scores 29 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 7 checks computed from SEC filings. Its best check is cash flow growth at 56.3%, and its weakest is return on capital at 0.6%. The Quality tab shows every check against its target.
Does Fortrea Holdings (FTRE) pay a dividend?
No. Fortrea Holdings (FTRE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 27 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 5 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in FTRE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing FTRE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.